
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
4.1N CRISPR/Cas9 KO Plasmid (m) | sc-420184 | 20 µg | $397.00 |
Epb41l1 encodes protein 4.1N, a neuron-enriched member of the protein 4.1 family that links the cortical actin/spectrin network to the plasma membrane to stabilize cell shape and membrane mechanics. 4.1N functions as a scaffolding factor at neuronal membranes and synapses, coordinating protein complex assembly that influences neurite outgrowth, synaptic organization, and vesicle trafficking. Through these cytoskeletal and membrane-coupling roles, Epb41l1 contributes to processes such as axon guidance and activity-dependent remodeling that are central to nervous system development and plasticity. Dysregulation of 4.1N-associated membrane–cytoskeleton architecture is relevant to studies of neurodevelopmental and neurodegenerative mechanisms where altered neuronal connectivity and excitability are key cellular phenotypes.
4.1N CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Epb41l1 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Epb41l1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Epb41l1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish 4.1N protein expression.
This CRISPR knockout system enables efficient generation of Epb41l1-deficient cell models for investigation of 4.1N signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.